Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1966 4
1967 2
1968 1
1969 1
1970 5
1971 3
1972 2
1973 3
1974 2
1975 1
1976 2
1977 4
1978 5
1979 3
1980 5
1981 7
1982 3
1983 9
1984 4
1985 11
1986 8
1987 4
1988 4
1989 6
1990 8
1991 5
1992 1
1993 5
1994 8
1995 9
1996 7
1997 8
1998 5
1999 4
2000 2
2001 3
2002 3
2003 3
2004 5
2005 8
2006 11
2007 9
2008 9
2009 13
2010 10
2011 17
2012 20
2013 20
2014 25
2015 32
2016 25
2017 34
2018 30
2019 32
2020 40
2021 40
2022 44
2023 42
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

600 results

Results by year

Filters applied: . Clear all
Page 1
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087. Chen R, et al. Among authors: tomita a. J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25. J Clin Oncol. 2017. PMID: 28441111 Free PMC article. Clinical Trial.
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087.
Chen R, Zinzani PL, Lee HJ, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH. Chen R, et al. Among authors: tomita a. Blood. 2019 Oct 3;134(14):1144-1153. doi: 10.1182/blood.2019000324. Epub 2019 Aug 13. Blood. 2019. PMID: 31409671 Free PMC article. Clinical Trial.
Class B1 GPCR activation by an intracellular agonist.
Kobayashi K, Kawakami K, Kusakizako T, Tomita A, Nishimura M, Sawada K, Okamoto HH, Hiratsuka S, Nakamura G, Kuwabara R, Noda H, Muramatsu H, Shimizu M, Taguchi T, Inoue A, Murata T, Nureki O. Kobayashi K, et al. Among authors: tomita a. Nature. 2023 Jun;618(7967):1085-1093. doi: 10.1038/s41586-023-06169-3. Epub 2023 Jun 7. Nature. 2023. PMID: 37286611 Free PMC article.
Five-year follow-up of KEYNOTE-087: pembrolizumab monotherapy for relapsed/refractory classical Hodgkin lymphoma.
Armand P, Zinzani PL, Lee HJ, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Herrera AF, Lin J, Kim E, Chakraborty S, Marinello P, Moskowitz CH. Armand P, et al. Among authors: tomita a. Blood. 2023 Sep 7;142(10):878-886. doi: 10.1182/blood.2022019386. Blood. 2023. PMID: 37319435 Free PMC article.
Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.
Ishikawa Y, Kawashima N, Atsuta Y, Sugiura I, Sawa M, Dobashi N, Yokoyama H, Doki N, Tomita A, Kiguchi T, Koh S, Kanamori H, Iriyama N, Kohno A, Moriuchi Y, Asada N, Hirano D, Togitani K, Sakura T, Hagihara M, Tomikawa T, Yokoyama Y, Asou N, Ohtake S, Matsumura I, Miyazaki Y, Naoe T, Kiyoi H. Ishikawa Y, et al. Among authors: tomita a. Blood Adv. 2020 Jan 14;4(1):66-75. doi: 10.1182/bloodadvances.2019000709. Blood Adv. 2020. PMID: 31899799 Free PMC article.
Structure and engineering of the minimal type VI CRISPR-Cas13bt3.
Nakagawa R, Kannan S, Altae-Tran H, Takeda SN, Tomita A, Hirano H, Kusakizako T, Nishizawa T, Yamashita K, Zhang F, Nishimasu H, Nureki O. Nakagawa R, et al. Among authors: tomita a. Mol Cell. 2022 Sep 1;82(17):3178-3192.e5. doi: 10.1016/j.molcel.2022.08.001. Epub 2022 Aug 25. Mol Cell. 2022. PMID: 36027912 Free PMC article.
A diffraction-quality protein crystal processed as an autophagic cargo.
Tsutsui H, Jinno Y, Shoda K, Tomita A, Matsuda M, Yamashita E, Katayama H, Nakagawa A, Miyawaki A. Tsutsui H, et al. Among authors: tomita a. Mol Cell. 2015 Apr 2;58(1):186-93. doi: 10.1016/j.molcel.2015.02.007. Epub 2015 Mar 12. Mol Cell. 2015. PMID: 25773597 Free article.
Long-Term Mastication Changed Salivary Metabolomic Profiles.
Saeki Y, Takenouchi A, Otani E, Kim M, Aizawa Y, Aita Y, Tomita A, Sugimoto M, Matsukubo T. Saeki Y, et al. Among authors: tomita a. Metabolites. 2022 Jul 18;12(7):660. doi: 10.3390/metabo12070660. Metabolites. 2022. PMID: 35888784 Free PMC article.
Anticholinergic Activity and Schizophrenia.
Tani M, Akashi N, Hori K, Konishi K, Kitajima Y, Tomioka H, Inamoto A, Hirata A, Tomita A, Koganemaru T, Takahashi A, Hachisu M. Tani M, et al. Among authors: tomita a. Neurodegener Dis. 2015;15(3):168-74. doi: 10.1159/000381523. Epub 2015 Jun 30. Neurodegener Dis. 2015. PMID: 26138495 Free article. Review.
600 results